People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PROFUSA, Inc. | — | Other Health Care | Series C | $60.3M | $1.0B | 2015 |
| Avirmax, Inc. | — | Biotechnology | Seed | $3.0M | $133.2M | 2019 |
Qianye Karen Liu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Qianye Karen Liu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Shengjiang Liu | 1 | 3 |
| Kristen Helton | 1 | 2 |
| Natalie Wisniewski | 1 | 1 |
| Thomas Gutshall | 1 | 1 |
| Ben Hwang | 1 | 1 |
| Yu Karen Fang | 1 | 1 |
| Haifeng Chen | 1 | 1 |
| Nancy Karen Chang | 1 | 1 |
| NG Siu Wai | 1 | 1 |
| Bill McMillan | 1 | 1 |
| Joan Siu Braddi | 1 | 1 |
| William Siu Frist | 1 | 1 |
| William McMillan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.